Srikala Addepalli, MBBS

Assistant Professor of Medicine
Email address srikala.addepalli@duke.edu

Education and Training

  • Hematology/Oncology Fellowship, The Brody School of Medicine at East Carolina University, 2014 - 2017
  • Internal Medicine Residency, University of Pennsylvania School of Medicine, 2011 - 2014
  • M.B.B.S., Gandhi Medical College and Hospital (India), 2002

Publications

Stroud, Chipman Rg, Aparna Hegde, Cynthia Cherry, Abdul R. Naqash, Nitika Sharma, Srikala Addepalli, Sulochana Cherukuri, Teresa Parent, Jessica Hardin, and Paul Walker. “Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade..” J Oncol Pharm Pract 25, no. 3 (April 2019): 551–57. https://doi.org/10.1177/1078155217745144.

PMID
29207939
Full Text

Addepalli, Srikala, Denise Brigham, and Darla K. Liles. “Unusual disease characteristics of multiple myeloma in eastern North Carolina..” In Journal of Clinical Oncology, 35:e19512–e19512. American Society of Clinical Oncology (ASCO), 2017. https://doi.org/10.1200/jco.2017.35.15_suppl.e19512.

Full Text

Addepalli, Srikala, Chipman Robert Geoffrey Stroud, Sulochana Devi Cherukuri, Cynthia R. Cherry, Nitika Sharma, Teresa Parent, Jessica Hardin, and Paul R. Walker. “Outcomes with immune checkpoint inhibitor use in lung cancer patients with hepatic metastases..” In Journal of Clinical Oncology, Vol. 35. AMER SOC CLINICAL ONCOLOGY, 2017.

Scholars@Duke

Sharma, Nitika, Chipman Robert Geoffrey Stroud, Paul R. Walker, Cynthia R. Cherry, Sulochana Devi Cherukuri, Srikala Addepalli, Teresa Parent, and Jessica Hardin. “Systemic inflammatory response syndrome (SIRS) with immune checkpoint inhibitors..” In Journal of Clinical Oncology, 34:3061–3061. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.15_suppl.3061.

Full Text